atenolol and lisinopril

atenolol has been researched along with lisinopril in 73 studies

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19904 (5.48)18.7374
1990's20 (27.40)18.2507
2000's19 (26.03)29.6817
2010's29 (39.73)24.3611
2020's1 (1.37)2.80

Authors

AuthorsStudies
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Avdeef, A; Tam, KY1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brunner, HR; Hayoz, D; Meister, JJ; Perret, F; Tardy, Y; Waeber, B1
Gerlin-Piira, L; Hämäläinen, K; Kyllönen, E; Kyllönen, T; Lonka, R; Parviainen, R; Selonen, R; Soininen, K; Suihkonen, J; Tikkanen, T1
Hedner, T; Herlitz, H; Ljungman, S; Pennert, K; Samuelsson, O; Widgren, B1
Huttunen, M; Ikäheimo, M; Kontro, J; Lampainen, E; Lilja, M; Mäkynen, P; Savolainen, A1
Boucher, CA; Christensen, DM; Higgins, J; Zusman, RM1
Darne, B; Fouchard, M; Garabedian, VG; Madonna, O; Pannier, BE; Safar, ME1
Admani, K; Angell-James, JE; Beevers, DG; Blackwood, RA; Feely, M; Garnham, S; Husaini, MH; Kumar, S; Mehrzad, AA; Watson, M1
Arriaga, J; Bernal, R; Bernardes, H; Bolzano, K; Calderon, JL; Debruyn, J; Dienstl, F; Drayer, J; Goodfriend, TL; Gross, W1
Cheung, DG; Graettinger, WF; Klein, RC; Lipson, JL; Weber, MA1
Goodman, C; Radford, HM; Rogers, GG; Rosendorff, C1
Parag, KB; Seedat, YK1
Fogari, R; Malamani, GD; Marasi, G; Vanasia, A; Villa, G; Zoppi, A1
Attwood, S; Bird, R; Burch, K; Casadei, B; Coats, A; Conway, J; Dawes, M; Ebbs, D; Farmer, A; Robinson, J1
Gall, MA; Nielsen, FS; Parving, HH; Rossing, P; Skøtt, P; Smidt, UM2
Amado, P; Araújo, V; Carmona, J; Castanheira, J; Nazaré, J1
Bakris, GL; Sadler, R; Slataper, R; Vicknair, N1
Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA1
Hedner, T; Lind, H; Lindholm, L; Rangemark, C; Samuelsson, O1
de Leeuw, PW; Notter, T; Zilles, P1
Chen, JW; Gall, MA; Nielsen, FS; Parving, HH; Rossing, P; Sato, A; Smidt, UM1
Corradi, L; Fogari, R; Lusardi, P; Mugellini, A; Poletti, L; Zoppi, A1
Keteyian, SJ; Levine, AB; Levine, TB; Narins, B1
Lee, TH1
Julve, R; Miralles, A; Pascual, JM; Redon, J; Rovira, E1
Faller, J; Hess, B1
Carabello, BA; De Freitas, G; Hamawaki, M; Nemoto, S1
Gao, L; Kern, TS; Widness, M; Xi, X; Zhang, JZ1
Grant, RW; Meigs, JB; Singer, DE1
Colon, P; Crow, R; Cutler, JA; Davis, BR; Dunn, K; Ellsworth, A; Franklin, S; Furberg, C; Goff, D; Golden, J; Leenen, F; Mohiuddin, S; Papademetriou, V; Piller, LB; Proschan, M1
Christian, R; Colon, PJ; Cushman, WC; Einhorn, PT; Ford, CE; Goff, DC; Henriquez, MA; Margolis, KL; Piller, LB; Vidt, DG; Wong, ND; Wright, JT1
Kumar, V; Shah, RP; Singh, S1
Fedulenkova, LV; Komissarenko, IA; Lazebnik, LB; Mikheeva, OM; Toporkov, AS; Vasnev, OS1
Christie, IC; Jennings, JR; Meltzer, CC; Muldoon, MF; Price, J1
Kumar, V; Malik, S; Singh, S1
Jennings, JR; Meltzer, CC; Muldoon, MF; Price, J; Scanlon, J; Whyte, EM1
Bestwick, JP; Law, M; Mills, S; Morris, JK; Wald, DS; Wald, NJ1
Christie, IC; Jennings, JR; Meltzer, CC; Muldoon, MF; Price, JC; Ryan, CM1
Adhikary, SD; Babu, SK; Korula, G; Ramachandran, A; Vedantam, R; Velayutham, PK1
Billot, L; Bompoint, S; Bots, ML; Cidambi, R; Field, J; Grobbee, DE; Patel, A; Poulter, N; Prabhakaran, D; Reddy, KS; Rodgers, A; Stanton, A; Thom, S1
Abraham, TN; Agarwal, R; Pappas, MK; Sinha, AD; Tegegne, GG1
Mallamaci, F; Zoccali, C1
Billot, L; Bompoint, S; Brown, A; Burch, C; Burke, H; Cass, A; Hayman, N; Hillis, GS; Jan, S; Molanus, B; Neal, B; Patel, A; Peiris, D; Rafter, N; Reid, CM; Rodgers, A; Shiel, L; Togni, S; Tonkin, A; Usherwood, T; Webster, R1
Jeffers, BW; Wang, JG; Yan, P1
Arroll, B; Bramley, D; Bryant, L; Bullen, C; Crengle, S; Doughty, RN; Elley, CR; Harwood, M; Jackson, R; Milne, RJ; Parag, V; Rafter, N; Rodgers, A; Selak, V; Wadham, A1
Beutler, D; Bosak, A; Graeme, K; Heise, CW; Loli, A; Orme, G1
Chirinos, JA; Townsend, RR1
Agarwal, R; Georgianos, PI3
Li, PK; Szeto, CC1
Amjad-Iranagh, S; Goharpey, F; Modarress, H; Yousefpour, A2
Agarwal, R1
Bots, ML; Grobbee, DE; Lafeber, M; Patel, A; Prabhakaran, D; Rodgers, A; Spiering, W; Stanton, A; Thom, S; Visseren, FL; Webster, R1
Beach, JL; Davis, BR; Ishak, A; Juraschek, SP; Mukamal, KJ; Shmerling, RH; Simpson, LM1

Reviews

3 review(s) available for atenolol and lisinopril

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
    Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic

2014
Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin.
    Seminars in dialysis, 2019, Volume: 32, Issue:6

    Topics: Atenolol; Diastole; Epoetin Alfa; Erythropoietin; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Kidney Failure, Chronic; Lisinopril; Male; Renal Dialysis; Risk Assessment; Systole; Vascular Stiffness; Water-Electrolyte Imbalance

2019

Trials

38 trial(s) available for atenolol and lisinopril

ArticleYear
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1992, Volume: 10, Issue:5

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atenolol; Blood Pressure; Captopril; Compliance; Dipeptides; Double-Blind Method; Humans; Hydralazine; Hypertension; Lisinopril; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography

1992
A study of the effects of lisinopril when used in addition to atenolol.
    Journal of human hypertension, 1992, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Heart Rate; Humans; Hypertension; Lisinopril; Middle Aged; Time Factors

1992
A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.
    European journal of clinical pharmacology, 1992, Volume: 43, Issue:5

    Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Dipeptides; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension; Kidney; Lisinopril; Male; Middle Aged

1992
Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic?
    Journal of human hypertension, 1992, Volume: 6, Issue:2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Lisinopril; Male; Middle Aged

1992
Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
    Cardiovascular drugs and therapy, 1991, Volume: 5, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Double-Blind Method; Enalapril; Humans; Hypertension; Lisinopril; Male; Middle Aged

1991
Lisinopril combined with atenolol in the treatment of hypertension. Swedish Lisinopril Study Group.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Double-Blind Method; Electrocardiography; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sweden

1991
Comparison of lisinopril versus atenolol for mild to moderate essential hypertension.
    The American journal of cardiology, 1991, Jan-01, Volume: 67, Issue:1

    Topics: Antihypertensive Agents; Atenolol; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged

1991
The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension.
    Journal of cardiovascular pharmacology, 1987, Volume: 9 Suppl 3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Random Allocation

1987
Effects of angiotensin converting enzyme inhibition and beta-blockade on exercise responses in hypertensive patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1988, Volume: 6, Issue:4

    Topics: Atenolol; Enalapril; Exercise Therapy; Hemodynamics; Humans; Hypertension; Lisinopril; Oxygen; Time Factors

1988
A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1987, Feb-07, Volume: 71, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Black People; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; India; Lisinopril; Male; Random Allocation; South Africa

1987
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    British journal of clinical pharmacology, 1995, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Fibrinogen; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Potassium; Triglycerides; Uric Acid

1995
Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.
    Journal of hypertension, 1994, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nifedipine; Renin

1994
Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Diabetes, 1994, Volume: 43, Issue:9

    Topics: Albuminuria; Apolipoproteins; Apoprotein(a); Atenolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Lipoprotein(a); Lisinopril; Male; Middle Aged; Potassium; Renin; Serum Albumin; Sodium; Time Factors; Triglycerides

1994
Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.
    Archives of internal medicine, 1993, Apr-26, Volume: 153, Issue:8

    Topics: Albuminuria; Antihypertensive Agents; Atenolol; Diabetic Nephropathies; Diltiazem; Dipeptides; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Lisinopril; Middle Aged; Prospective Studies; Renal Circulation

1993
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure

1996
Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension.
    European journal of clinical pharmacology, 1996, Volume: 49, Issue:4

    Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Cross-Over Studies; Double-Blind Method; Exercise; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged

1996
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
    Journal of hypertension, 1997, Volume: 15, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil

1997
Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
    Diabetes, 1997, Volume: 46, Issue:7

    Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney; Lisinopril; Male; Middle Aged; Prospective Studies; Rabbits; Single-Blind Method; Time Factors

1997
Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Scandinavian journal of clinical and laboratory investigation, 1997, Volume: 57, Issue:5

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Patient Compliance; Prospective Studies; Renin

1997
Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study.
    American journal of hypertension, 1998, Volume: 11, Issue:10

    Topics: Adult; Antihypertensive Agents; Atenolol; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Libido; Lisinopril; Male; Middle Aged; Sex Characteristics; Sexual Behavior

1998
The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Clinical cardiology, 1998, Volume: 21, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Cohort Studies; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome; Vasodilator Agents

1998
Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
    Hypertension (Dallas, Tex. : 1979), 2002, Mar-01, Volume: 39, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bisoprolol; Calcium Channel Blockers; Enalapril; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Nifedipine; Proportional Hazards Models; Regression Analysis; Risk Factors; Treatment Outcome

2002
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Circulation, 2006, May-09, Volume: 113, Issue:18

    Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Diuretics; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hypertension; Incidence; Lisinopril; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Risk; Treatment Outcome

2006
Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
    Hypertension (Dallas, Tex. : 1979), 2007, Volume: 50, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Canada; Chlorthalidone; Clonidine; Double-Blind Method; Doxazosin; Female; Heart Diseases; Hispanic or Latino; Humans; Hydralazine; Hypertension; Hypolipidemic Agents; Lisinopril; Male; Middle Aged; Puerto Rico; Reserpine; Treatment Outcome; United States; United States Virgin Islands; White People

2007
[Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:5

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Enalapril; Female; Hemodynamics; Humans; Hypertension, Portal; Lisinopril; Liver; Liver Cirrhosis, Alcoholic; Male; Metoprolol; Middle Aged; Treatment Outcome

2007
Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Brachial Artery; Brain; Cerebrovascular Circulation; Cognition; Cognition Disorders; Female; Heart Rate; Humans; Hypertension; Lisinopril; Male; Memory; Middle Aged; Vasodilation

2008
Brain imaging findings predict blood pressure response to pharmacological treatment.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:6

    Topics: Aging; Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Cerebrovascular Circulation; Cognition Disorders; Female; Humans; Hypertension; Lisinopril; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Regression Analysis

2008
A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Clinical therapeutics, 2008, Volume: 30, Issue:11

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Regression Analysis; Time Factors; Treatment Outcome

2008
Brain function, cognition, and the blood pressure response to pharmacological treatment.
    Psychosomatic medicine, 2010, Volume: 72, Issue:7

    Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Brain Mapping; Cerebrovascular Circulation; Cognition; Cognition Disorders; Female; Humans; Hypertension; Lisinopril; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Regional Blood Flow; Tomography, Emission-Computed

2010
Oxidative stress-associated hypertension in surgically induced brain injury patients: effects of β-blocker and angiotensin-converting enzyme inhibitor.
    The Journal of surgical research, 2013, Volume: 179, Issue:1

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Craniotomy; Double-Blind Method; Female; Humans; Hypertension; Lipid Peroxidation; Lisinopril; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Protein Carbonylation; Supratentorial Neoplasms; Treatment Outcome; Young Adult

2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
    JAMA, 2013, Sep-04, Volume: 310, Issue:9

    Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Female; Humans; Hydrochlorothiazide; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Simvastatin; Treatment Outcome

2013
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:3

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Treatment Failure

2014
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
    European journal of preventive cardiology, 2015, Volume: 22, Issue:7

    Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Atenolol; Australia; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Drug Combinations; Drugs, Generic; Female; General Practice; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lisinopril; Male; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Primary Prevention; Prospective Studies; Risk Factors; Simvastatin; Sodium Chloride Symporter Inhibitors; Tablets; Time Factors; Treatment Outcome

2015
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    BMJ (Clinical research ed.), 2014, May-27, Volume: 348

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lisinopril; Male; Medication Adherence; Middle Aged; New Zealand; Primary Health Care; Regression Analysis; Risk Factors; Simvastatin; Young Adult

2014
Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
    Clinical journal of the American Society of Nephrology : CJASN, 2015, Apr-07, Volume: 10, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; Indiana; Kidney Diseases; Lisinopril; Male; Middle Aged; Pulse Wave Analysis; Renal Dialysis; Time Factors; Treatment Outcome; Vascular Stiffness

2015
Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:2

    Topics: Adult; Aged; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure Monitoring, Ambulatory; Early Termination of Clinical Trials; Echocardiography, Doppler; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Pulse Wave Analysis; Renal Dialysis; Treatment Outcome; Vascular Stiffness

2015
Treating hypertension in hemodialysis improves symptoms seemingly unrelated to volume excess.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:1

    Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Blood Volume; Body Weight; Female; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Renal Dialysis; Treatment Outcome

2016
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
    European journal of preventive cardiology, 2017, Volume: 24, Issue:9

    Topics: Administration, Oral; Aged; Antihypertensive Agents; Aspirin; Atenolol; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Drug Combinations; Drug Substitution; Europe; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Lisinopril; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Polypharmacy; Risk Assessment; Risk Factors; Simvastatin; Tablets; Time Factors; Treatment Outcome

2017

Other Studies

32 other study(ies) available for atenolol and lisinopril

ArticleYear
Interaction of digoxin with antihypertensive drugs via MDR1.
    Life sciences, 2002, Feb-15, Volume: 70, Issue:13

    Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors

2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:2

    Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiac Output; Dipeptides; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Male; Middle Aged; Vascular Resistance; Ventricular Function, Left

1992
Comparison of antihypertensive therapies by noninvasive techniques.
    Chest, 1989, Volume: 96, Issue:1

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure Determination; Echocardiography; Enalapril; Humans; Hypertension; Lisinopril; Male; Middle Aged; Monitoring, Physiologic; Time Factors

1989
[Paroxysmal atrial fibrillation and flutter and "occult" arterial hypertension. The importance of the ambulatory monitoring of the blood pressure. Apropos 2 cases].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1993, Volume: 12, Issue:10

    Topics: Atenolol; Atrial Fibrillation; Atrial Flutter; Blood Pressure Monitors; Diltiazem; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Male; Middle Aged; Verapamil

1993
Ask the doctor. I take atenolol and lisinopril for my blood pressure. I have a blood pressure monitor that I use at home and I find that, on average, my pressure is 150/85 in the morning and 130/80 in the afternoon. Should I be worried about the high morn
    Harvard heart letter : from Harvard Medical School, 2000, Volume: 10, Issue:7

    Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Humans; Hypertension; Lisinopril

2000
[Medicamentous kidney protection in type 2 diabetic patients--is cheaper also more economical? A model calculation for Swiss health care].
    Praxis, 2002, May-08, Volume: 91, Issue:19

    Topics: Adult; Antihypertensive Agents; Atenolol; Cost Savings; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Costs; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Models, Economic; Switzerland; Verapamil

2002
Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
    Journal of the American College of Cardiology, 2002, Jul-03, Volume: 40, Issue:1

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Dogs; Hemodynamics; Lisinopril; Male; Mitral Valve Insufficiency; Myocardial Contraction; Ventricular Function, Left

2002
Captopril inhibits glucose accumulation in retinal cells in diabetes.
    Investigative ophthalmology & visual science, 2003, Volume: 44, Issue:9

    Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Blood Glucose; Blotting, Western; Captopril; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Glucose; Glucose Transporter Type 1; Lisinopril; Male; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels

2003
[Regulatory-adaptive abilities of hypertensive patients treated with lisinopril and atenolol].
    Terapevticheskii arkhiv, 2005, Volume: 77, Issue:3

    Topics: Adaptation, Physiological; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged

2005
Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Clinical therapeutics, 2005, Volume: 27, Issue:6

    Topics: Adult; Aging; Antihypertensive Agents; Atenolol; Case-Control Studies; Cohort Studies; Drug Prescriptions; Female; Humans; Hydrochlorothiazide; Hypertension; Insurance Claim Review; Insurance, Pharmaceutical Services; Lisinopril; Male; Middle Aged; Patient Compliance; Prospective Studies; Time Factors

2005
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products.
    Journal of pharmaceutical and biomedical analysis, 2008, Jul-15, Volume: 47, Issue:3

    Topics: Aspirin; Atenolol; Atorvastatin; Cardiovascular Agents; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Heptanoic Acids; Hydrochlorothiazide; Lisinopril; Pravastatin; Pyrroles; Simvastatin; Spectrometry, Mass, Electrospray Ionization

2008
Polypill for the treatment of cardiovascular diseases part 2. LC-MS/TOF characterization of interaction/degradation products of atenolol/lisinopril and aspirin, and mechanisms of formation thereof.
    Journal of pharmaceutical and biomedical analysis, 2008, Nov-04, Volume: 48, Issue:3

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atenolol; Cardiovascular Agents; Chromatography, Liquid; Drug Combinations; Drug Interactions; Lisinopril; Mass Spectrometry; Molecular Structure; Molecular Weight; Platelet Aggregation Inhibitors

2008
Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:3

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiotonic Agents; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic

2014
Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2015, Volume: 11, Issue:1

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Atenolol; Cardiovascular Agents; Chlorthalidone; Combined Modality Therapy; Decontamination; Drug Overdose; Emergency Service, Hospital; Endoscopy, Digestive System; Extracorporeal Membrane Oxygenation; Female; Humans; Lisinopril; Multiple Organ Failure; Renal Dialysis; Shock, Cardiogenic; Tablets; Transcutaneous Electric Nerve Stimulation; Treatment Outcome

2015
Reducing arterial stiffness in CKD: revising the paradigms.
    Clinical journal of the American Society of Nephrology : CJASN, 2015, Apr-07, Volume: 10, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Female; Humans; Kidney Diseases; Lisinopril; Male; Renal Dialysis; Vascular Stiffness

2015
Cardiovascular disease: Questioning the effect of β-blockers on vascular stiffness.
    Nature reviews. Nephrology, 2015, Volume: 11, Issue:8

    Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Female; Humans; Kidney Diseases; Lisinopril; Male; Renal Dialysis; Vascular Stiffness

2015
Interaction of PEGylated anti-hypertensive drugs, amlodipine, atenolol and lisinopril with lipid bilayer membrane: A molecular dynamics simulation study.
    Biochimica et biophysica acta, 2015, Volume: 1848, Issue:8

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Diffusion; Dimyristoylphosphatidylcholine; Energy Transfer; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Lisinopril; Molecular Dynamics Simulation; Molecular Structure; Polyethylene Glycols; Software; Static Electricity; Structure-Activity Relationship; Time Factors; Water

2015
Combination of anti-hypertensive drugs: a molecular dynamics simulation study.
    Journal of molecular modeling, 2017, Volume: 23, Issue:5

    Topics: Amlodipine; Antihypertensive Agents; Atenolol; Dimyristoylphosphatidylcholine; Humans; Hydrogen Bonding; Hypertension; Lipid Bilayers; Lisinopril; Molecular Conformation; Molecular Dynamics Simulation; Software; Water

2017
The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Journal of hypertension, 2020, Volume: 38, Issue:5

    Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Female; Gout; Humans; Hypertension; Lisinopril; Male; Middle Aged; Myocardial Infarction; Treatment Outcome

2020